About Us Products Pipeline Investors & News Careers Contact Us Products From Concept through Commercialization: Osmotica Meets Patient Needs Products We sell a diverse portfolio consisting of five promoted products and approximately 35 non-promoted products, several of which incorporate our proprietary Osmodex® drug delivery system. Our non-promoted product portfolio includes methylphenidate HCl ER tablets and venlafaxine HCl ER tablets and prescription and non-prescription dietary supplements. We invite you to review the product websites and full prescribing information for more information. Methylphenidate HCl ER 72 mg Tablets (M-72) www.methylphenidateer72.com/ Lorzone® (chlorzoxazone USP) Tablet prescribing information ConZip® (tramadol hydrochloride) Extended-Release Capsules prescribing information Divigel® (estradiol gel) 0.1% www.divigel.com/ OB Complete® www.obcomplete.com/ Drug Safety Patient safety is our highest priority, and it is our responsibility to monitor the safety of the products we develop. If you are a patient experiencing a potential adverse event or if you have questions about your condition, please contact your health care practitioner. To report an adverse event or a product complaint about our products, please contact us at: Phone: 1-877-482-3788 or the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088. For additional information about our products, please visit www.VerticalPharma.com and www.TrigenLab.com. © 2021 Osmotica Pharmaceuticals plc. All Rights Reserved A public limited company Registered in Ireland Registration Number: 607944 Registered office: 25-28 North Wall Quay, Dublin 1, Ireland Terms of Use Privacy Policy